Commonwealth Equity Services
IRD

Commonwealth Equity Services’s Opus Genetics IRD Stock Holding History

Commonwealth Equity Services’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,739
Closed -$15K – 4236
2024
Q3 		$15K Buy
+11,739
New +$18.1K ﹤0.01% 4018
2015
Q1 		– Sell
-49
Closed -$16K – 2229
2014
Q4 		$16K Hold
49
– – ﹤0.01% 2073
2014
Q3 		$19K Sell
49
-175
-78% -$63K ﹤0.01% 2056
2014
Q2 		$94K Buy
224
+32
+17% +$14.5K ﹤0.01% 1945
2014
Q1 		$99K Buy
192
+123
+178% +$66.5K ﹤0.01% 1888
2013
Q4 		$17K Hold
69
– – ﹤0.01% 1913
2013
Q3 		$15K Sell
69
-42
-38% -$9.8K ﹤0.01% 1857
2013
Q2 		$24K Buy
+111
New +$19.1K ﹤0.01% 1783

Other funds holding IRD

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return

Commonwealth Equity Services's IRD Position: Q4 2024 in Review

Commonwealth Equity Services sold out of Opus Genetics (IRD) in Q4 2024, closing a stake of 11,739 shares — an estimated $15K sold.

Commonwealth Equity Services first reported a position in IRD in Q2 2013 and held it in 8 quarters. The position peaked at $99K in Q1 2014. 43 funds tracked by Wall St. Rank hold IRD as of Q4 2024.

  • Commonwealth Equity Services reported no remaining Opus Genetics position as of Q4 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 11,739 Opus Genetics shares in Q4 2024, an estimated $15K.
  • Commonwealth Equity Services first reported a position in Opus Genetics in Q2 2013 and held it in 8 quarters.
  • Commonwealth Equity Services's Opus Genetics position peaked at $99K in Q1 2014.
  • 43 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2024.

Based on Commonwealth Equity Services's 13F filing for Q4 2024, filed 10 Feb 2025.